Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The GLI family zinc finger 1 (GLI1) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory sequence located at the 3' end of the GLI1 transcript, which encodes the primary transcriptional activator of the Hedgehog (Hh) signaling pathway (UniProt P08151). This region serves as a scaffold for various microRNAs, such as miR-324-5p and miR-133b, and RNA-binding proteins that modulate the stability and translation of the mRNA (Ferretti et al., 2008, Nature Genetics). In many cancers, including medulloblastoma and basal cell carcinoma, the GLI1 3'-UTR is involved in the dysregulation of Hh signaling, often through the loss of microRNA-mediated suppression, leading to overexpression of the GLI1 protein and subsequent tumor growth (PubMed: 18469814). As a therapeutic target, the GLI1 mRNA is targeted by RNA-based therapies such as the antisense oligonucleotide ISIS 183750 (IONIS-GLI1Rx), which was developed to reduce GLI1 levels by inducing mRNA degradation. These approaches are particularly valuable for treating tumors that have developed resistance to upstream Hh pathway inhibitors like vismodegib, which target the Smoothened (SMO) receptor. By directly targeting the mRNA of the terminal effector, these strategies provide a more direct method of pathway inhibition in GLI-dependent malignancies.
Antisense-mediated degradation of GLI1 mRNA via RNase H recruitment or RNA interference (RNAi) to suppress GLI1 protein synthesis.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GLI family zinc finger 1 mRNA 3'-untranslated region (GLI1 mRNA 3'-UTR) (GLI1 mRNA 3'-UTR).